Nonpharmacologic treatment and prevention strategies for dementia

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 2, 2013, Pages 372-381

  Yaffe, Kristine ^a   Hoang, Tina ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; DEMENTIA; DIET THERAPY; LIFESTYLE MODIFICATION; NUTRITION; PHYSICAL ACTIVITY; PREVENTIVE MEDICINE; REVIEW; RISK REDUCTION; SLEEP QUALITY; SOCIAL BEHAVIOR;

AGED; CARDIOVASCULAR DISEASES; DEMENTIA; FEMALE; HUMANS; LIFE STYLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SLEEP DISORDERS; SMOKING;

EID: 84876375751     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000429178.14354.67     Document Type: Review

References (62)

1. Daviglus ML, Bell CC, Berrettini W, et al. National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med 2010;153(3):176-181.
2. Tolppanen A-M, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J Alzheimers Dis 2012;32(3):531-540.
3. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292(18): 2237-2242.
4. Peltz CB, Corrada MM, Berlau DJ, Kawas CH. Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors. Alzheimers Dement 2012;8(2):87-94.
5. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 2011;68(10): 1239-1244.
6. Shepardson N, Shankar G, Selkoe D. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 2011;68(11): 1385-1392.
7. Kennelly S, Collins O. Walking the cognitive "minefield" between high and low blood pressure. J Alzheimers Dis 2012;32(3):609-621.
8. Staessen JA, Thijs L, Richart T, et al. Placebo-controlled trials of blood pressureYlowering therapies for primary prevention of dementia. Hypertension 2011;57(2):e6-e7.
9. Systolic Blood Pressure Intervention Trial (SPRINT). Clinicaltrials.gov. www.clinicaltrials. gov/ct2/show/NCT01206062. Updated December 6, 2010. Accessed November 1, 2012.
10. Zeki Al Hazzouri A, Haan MN, Whitmer RA, et al. Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord 2012;33(6):400-409.
11. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 2011;12(5): e426-e437.
12. Siervo M, Arnold R, Wells JCK, et al. Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysis. Obes Rev 2011;12(11):968-983.
13. Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010;67(6):505-512.
14. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012;69(9):1170-1175.
15. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012;69(1):29-38.
16. Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 2011;86(9):876-884.
17. Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 2011;269(1):107-117.
18. Erickson KI, Raji CA, Lopez OL, et al. Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology 2010;75(16):1415-1422.
19. Tierney MC, Moineddin R, Morra A, et al. Intensity of recreational physical activity throughout life and later life cognitive functioning in women. J Alzheimers Dis 2010;22(4):1331-1338.
20. Smith PJ, Blumenthal JA, Hoffman BM, et al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 2010;72(3):239-252.
21. Littbrand H, Stenvall M, Rosendahl E. Applicability and effects of physical exercise on physical and cognitive functions and activities of daily living among people with dementia: a systematic review. Am J Phys Med Rehabil 2011;90(6):495-518.
22. Meng X, D'Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One 2012;7(6):e38268.
23. Yaffe K, Weston A, Graff-Radford NR, et al. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 2011;305(3):261-266.
24. Valenzuela MJ, Matthews FE, Brayne C, et al. Multiple biological pathways link cognitive lifestyle to protection from dementia. Biol Psychiatry 2012;71(9):783-791.
25. Treiber KA, Carlson MC, Corcoran C, et al. Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. J Gerontol B Psychol Sci Soc Sci 2011;66(4):416-425.
26. Landau SM, Marks SM, Mormino EC, et al. Association of lifetime cognitive engagement and low γ-amyloid deposition. Arch Neurol 2012;69(5):623-629.
27. Lachman ME, Agrigoroaei S, Murphy C, Tun PA. Frequent cognitive activity compensates for education differences in episodic memory. Am J Geriatr Psychiatry 2010;18(1):4-10.
28. Gates N, Sachdev P, Fiatarone Singh M, Valenzuela M. Cognitive and memory training in adults at risk of dementia: a systematic review. BMC Geriatr 2011;11:55.
29. Woods B, Aguirre E, Spector A, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012;2: CD005562.
30. Crooks VC, Lubben J, Petitti DB, et al. Social network, cognitive function, and dementia incidence among elderly women. Am J Public Health 2008;98(7):1221-1227.
31. Stoykova R, Matharan F, Dartigues JF, Amieva H. Impact of social network on cognitive performances and age-related cognitive decline across a 20-year follow-up. Int Psychogeriatr 2011;1-8.
32. Amieva H, Stoykova R, Matharan F, et al. What aspects of social network are protective for dementia? Not the quantity but the quality of social interactions is protective up to 15 years later. Psychosom Med 2010; 72(9):905-911.
33. Pitkala KH, Routasalo P, Kautiainen H, et al. Effects of socially stimulating group intervention on lonely, older people's cognition: a randomized, controlled trial. Am J Geriatr Psychiatry 2011;19(7):654-663.
34. Mortimer JA, Ding D, Borenstein AR, et al. Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders. J Alzheimers Dis 2012;30(4):757-766.
35. Benton D. Neurodevelopment and neurodegeneration: are there critical stages for nutritional intervention? Nutr Rev 2010;68(suppl 1):S6-S10.
36. Morris MC. Nutritional determinants of cognitive aging and dementia. Proc Nutr Soc 2012;71(1):1-13.
37. Wald DS, Kasturiratne A, Simmonds M. Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med 2010;123(6): 522-527.e2.
38. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial [erratum published in JAMA 2008;300(23): 2730]. JAMA 2008;300(19):2253-2262.
39. Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012; 11(10):851-859.
40. Dangour AD, Andreeva VA, Sydenham E, Uauy R. Omega 3 fatty acids and cognitive health in older people. B J Nutr 2012; 107(suppl 2):S152-S158.
41. Mazereeuw G, Lanctôt KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging 2012;33(7):1482.e1417-1482.e1429.
42. Scarmeas N, Stern Y, Mayeux R, et al. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009;66(2): 216-225.
43. Gu Y, Scarmeas N. Dietary patterns in Alzheimers disease and cognitive aging. Curr Alzheimer Res 2011;8(5):510-519.
44. Bowman GL, Silbert LC, Howieson D, et al. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 2012;78(4):241-249.
45. Harris E, Macpherson H, Vitetta L, et al. Effects of a multivitamin, mineral and herbal supplement on cognition and blood biomarkers in older men: a randomised, placebo-controlled trial. Hum Psychopharmacol 2012;27(4):370-377.
46. Remington R, Chan A, Paskavitz J, Shea TB. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study. Am J Alzheimers Dis Other Demen 2009; 24(1):27-33.
47. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166(4):367-378.
48. Debette SMD, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77(5):461-468.
49. Gons RAR, van Norden AG, de Laat KF, et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain 2011;134(pt 7):2116-2124.
50. Almeida OP, Garrido GJ, Alfonso H, et al. 24-Month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage 2011;55(4):1480-1489.
51. Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009;17(7):542-555.
52. Collins M, Neafsey E, Wang K, Achille N, Mitchell R, Sivaswamy S. Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms. Mol Neurobiol 2010;41(2-3):420-425.
53. Bombois S, Derambure P, Pasquier F, Monaca C. Sleep disorders in aging and dementia. J Nutr Health Aging 2010;14(3):212-217.
54. Beebe DW. Cognitive, behavioral, and functional consequences of inadequate sleep in children and adolescents. Pediatr Clin North Am 2011;58(3):649-665.
55. Elwood PC, Bayer AJ, Fish M, et al. Sleep disturbance and daytime sleepiness predict vascular dementia. J Epidemiol Community Health 2011;65(9):820-824.
56. Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011; 306(6):613-619.
57. Tranah GJ, Blackwell T, Stone KL, et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 2011;70(5):722-732.
58. Cooke JR, Ayalon L, Palmer BW, et al. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med 2009;5(4):305-309.
59. Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69(1):163-169.
60. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011; 10(9):819-828.
61. Andrieu S, Aboderin I, Baeyens J, et al. IAGG Workshop: health promotion program on prevention of late onset dementia. J Nutr Health Aging 2011;15(7):562-575.
62. Richard E, den Heuvel EV, Moll van Charante EP, et al. Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord 2009;23(3): 198-204.